Company Description
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the Americas, Europe, the Middle East, Africa, China, and the Asia Pacific.
It offers Chromium platform that enables analysis of individual biological components, as well as includes microfluidic chips and related consumables, Chromium X Series, and Chromium instruments; Visium platform includes Spatial Gene Expression, HD Spatial Gene Expression, and Spatial Gene and Protein Expression assays, as well as the Visium CytAssist, an instrument designed to simplify and optimize the Visium solution workflow by facilitating the transfer of transcriptomic analytes from standard glass slides to Visium slides; and Xenium Analyzer instrument enables researchers to detect and preserve the cellular location of hundreds of RNA targets directly in a fresh frozen or FFPE tissue section.
It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014.
10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.
| Country | United States |
| Founded | 2012 |
| IPO Date | Sep 12, 2019 |
| Industry | Health Information Services |
| Sector | Healthcare |
| Employees | 1,306 |
| CEO | Serge Saxonov |
Contact Details
Address: 6230 Stoneridge Mall Road Pleasanton, California 94588-3260 United States | |
| Phone | 925 401 7300 |
| Website | 10xgenomics.com |
Stock Details
| Ticker Symbol | TXG |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Share Class | Class A Shares |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $39.00 |
| CIK Code | 0001770787 |
| CUSIP Number | 88025U109 |
| ISIN Number | US88025U1097 |
| Employer ID | 45-5614458 |
| SIC Code | 3826 |
Key Executives
| Name | Position |
|---|---|
| Dr. Serge Saxonov Ph.D. | Co-Founder, Chief Executive Officer and Director |
| Dr. Benjamin J. Hindson Ph.D. | Co-Founder, President, Chief Scientific Officer and Director |
| Eric S. Whitaker Esq. | Chief Legal Officer |
| Adam S. Taich | Chief Financial Officer, Treasurer, Principal Financial Officer and Principal Accounting Officer |
| Jim Goodrich | Chief of Global Operations |
| Michael Schnall-Levin | Founding Scientist and Chief Technology Officer |
| Alexander Wong | Chief Information Officer |
| Cassie Corneau | Manager of Investor Relations and Strategic Finance |
| Rebecca Port | Chief People Officer |
| Mennah Moustafa | Chief Commercial Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Feb 28, 2025 | 144 | Filing |
| Feb 24, 2025 | 144 | Filing |
| Feb 24, 2025 | 144 | Filing |
| Feb 13, 2025 | S-8 | Securities to be offered to employees in employee benefit plans |
| Feb 13, 2025 | 10-K | Annual Report |
| Feb 12, 2025 | 8-K | Current Report |
| Jan 13, 2025 | 8-K | Current Report |
| Nov 22, 2024 | 144 | Filing |
| Nov 22, 2024 | 144 | Filing |
| Nov 8, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |